Benno Therapeutics
1006.661.347 · rovalta.com · 25/09/2026
Benno Therapeutics
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOBenno Therapeutics is a Private limited company incorporated in 2024. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Leuven.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 1006.661.347
- Incorporation
- 01/03/2024
- Legal form
- Private limited company
- Registered office
- Ambachtenlaan 1
3001 Leuven · FlandreSee on map - Contributed capital
- 283 442,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 1 filingTrend over 1 financial year
| 2025 | |
|---|---|
| Income statement | |
| Gross margin | -194 k € |
| EBITDA | -194 k € |
| Operating result | -782,8 k € |
| Net result | -790,2 k € |
| Balance sheet | |
| Equity | -506,8 k € |
| Total assets | 56,7 k € |
| Cash | 35,4 k € |
| Debts | 556,7 k € |
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
Other companies at this address
Ambachtenlaan 1 3001 Leuven| Company | CBE no. |
|---|---|
BIOHUB LEUVEN● Bankrupt | 0758.747.955 |
RheADC● Active | 1014.500.036 |
Tailored Lab Solutions Belgium● Active | 1034.130.262 |
Financials
Full financial information
Source · NBB| 2025 | |
|---|---|
| Type of account | Abridged model |
| Start of the financial year | 01/03/2024 |
| Closing of the financial year | 31/12/2025 |
| Length of the financial year | 22 months |
| Filing date | 15/06/2026 |
| General meeting | 04/06/2026 |
| Currency of the financial year | EUR |
| NBB quality label | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 1 filing| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 04/06/2026 | 15/06/2026 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-790,2 k €
- 01/03/2024IncorporationPrivate limited company